Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical pentane-1,5-diol hydrogel for impetigo
2005-000808-14Phase 2Completed
- Sponsor
- Ambria Dermatology
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pentane-1,5-diol in impetigo (2 arms), sponsored by Ambria Dermatology. Primary endpoint: Successfully treated cases. Started Feb 2005; status: completed.
02
Drugs
pentane-1,5-diol
03
Conditions
impetigo
Beyond the preview
Go deeper on 2005-000808-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000808-14.